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Abstract
Background: Single chain Fvs (scFvs) are widely applied in research, diagnostics and therapeutic settings. Display
and selection from combinatorial libraries is the main route to their discovery and many factors influence the
success of this process. They exhibit low thermodynamic stability, resulting in low levels of premature cytosolic
folding or aggregation which facilitates sec YEG-mediated translocation and phage in E. coli. However, there is little
data analysing how this is related to and influenced by scFv protein expression.
Results: We characterised the relationship between overall scFv expression and display propensity for a panel
of 15 anti-tetanus toxin scFvs and found a strong positive correlation (Rho = 0.88, p < 0.005) between the two
parameters. Display propensity, overall expression and soluble localisation to the periplasm and extracellular
fractions were clone specific characteristics which varied despite high levels of sequence homology. There was
no correlation between display of scFv or its expression in non-fused (free) form with soluble scFv localisation to
the periplasm or culture supernatant. This suggests that divergence in the fate of scFv-pIII and non-fused scFv after
translocation to the periplasm accounts for the observed disparity. Differential degrees of periplasmic aggregation
of non-fused scFv between clones may affect the partitioning of scFv in the periplasm and culture supernatant
abrogating any correlation. We suggest that these factors do not apply to the scFv-pIII fusion since it remains
anchored to the bacterial inner membrane as part of the innate phage packaging and budding process.
Conclusion: We conclude that in the absence of premature cytosolic aggregation or folding, the propensity of
a scFv to be displayed on phage is directly related to its overall expression level and is thus indirectly influenced
by factors such as codon bias, mRNA abundance or putative DNA motifs affecting expression. This suggests that
scFvs capable of high overall expression and display levels may not produce high yields of non phage-fused soluble
protein in either the periplasmic or extracellular fractions of E. coli. This should be considered when screening
clones selected from combinatorial libraries for further study.
The nucleotide and amino acid sequences of the anti-tetanus toxin scFvs have been deposited in the EMBL data 
base: accession numbers-C1: AM749134, C2: AM749135, C3: AM749136, C4: AM749137, C5: AM749138, N1: 
AM749139, N2: AM749140, N3: AM749141, N4: AM749142, N5: AM749143 J1; AM749144, J2: AM749145, J3: 
AM749146, J4: AM749147, J5: AM749148.
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During the last two decades single chain Fv (scFv) anti-
bodies have become widely applied in research, diagnos-
tics and therapeutic settings [1]. These recombinant,
antigen-binding molecules can be engineered [2,3] to
modulate their specificity [4] affinity [5] and pharmacok-
inetics [6] as well as appending novel effector functions
[7,8] Established technology allows investigators to pro-
duce large and diverse combinatorial scFv libraries com-
monly using minor coat protein (pIII) filamentous phage
display in Escherichia coli (E. coli) [9-12]. During produc-
tion of phage-scFvs, the scFv-pIII fusion is translocated to
the periplasmic space and remains anchored in the
cytosolic membrane by the C-terminal hydrophobic
extension of pIII [13]. The fusion protein then assembles
with nascent phage particles as they extrude from the
inner membrane.
Overall levels of scFv expression, as with all proteins, are
dependant on transcriptional, post-transcriptional and
translational level gene regulation. It has been shown that
47% of the variation in E. coli protein abundance is
accounted for by mRNA abundance alone and codon-bias
and codon adaptation indices account for a major propor-
tion of the remaining variation [14,15]. Expression yield
often refers to the level of soluble protein produced in the
E. coli which may be located in the periplasm or in culture
supernatant. High thermodynamic stability, high molecu-
lar weight, increased hydrophobicity and areas of low
sequence complexity are linked to poor soluble protein
expression yields [16]. Such properties can lead to pro-
teins being more susceptible to proteolytic degradation
[17] aggregation and inclusion body formation in either
the cytosol [18] or periplasmic space [19,20]. Disulphide-
rich proteins may also be prone to mis-folding once in the
periplasm [21].
There is a multitude of research demonstrating that
improvements in soluble expression yields in either the
periplasm or supernatant can typically be gained by
approaches including removal of detrimental hydropho-
bic residues [22,23], alteration of leader sequence [24],
co-expression or over-expression of cytosolic or periplas-
mic chaperones [25,26] or modifying induction condi-
tions such as inducer concentration, temperature or time
[27,28].
Some processes affecting soluble protein expression yield
also have bearing upon phage display. In phagemid vector
systems [29] the protein-pIII fusion is targeted to the peri-
plasm in the same manner as non-fused protein as they
share the same leader sequence. Proteins refractory to
SecYEG-mediated periplasmic translocation therefore
tend to display poorly in standard phage display systems,
elegantly shown for DARPins which have very high ther-
modynamic stability and are prone to premature folding
and aggregation in the cytosol post-translationally [30].
Display levels and periplasmic localisation were drasti-
cally improved when the leader sequence was altered for
utilisation of the co-translational translocation signal rec-
ognition particle pathway which does not allow prema-
ture folding or aggregation. This study concluded that
when comparing a diverse range of proteins, overall
expression level may not correlate with phage display pro-
pensity but soluble periplasmic levels do.
There is little data available indicating how overall protein
expression level relates to display propensity in the
absence of dysfunctional cytosolic-periplasmic protein
translocation. The scFv, which is known for its lower ther-
modynamic stability [31] tends not to prematurely fold in
the cytosol of bacteria and is amenable to display and
localisation to the periplasm regardless of whether a post
or co-translational translocation approach is used [30,32].
Comparing a panel of scFvs in terms of overall protein
expression and phage display propensity allows the link
between the two characteristics to be investigated.
We used phage display to select scFvs against the recom-
binant C-terminal domain of the tetanus toxin heavy
chain (HC) (Scott, N. et al, manuscript in preparation)
from a Cambridge Antibody Technology library contain-
ing 1.4 × 1010 clones [29]. After two rounds of display we
isolated many HC-specific clones exhibiting complimen-
tarity determining region (CDR) diversity (Scott et al,
manuscript in preparation). The scFvs consist of an N-ter-
minal SecYEG translocon signal sequence (VKKLL-
FAIPLVVPFYAAQPAMA) [29] and C-terminal hexa-
histidine (his6) and c-myc tags. We sought to compare the
phage display properties of 15 anti-Hc scFvs (termed C1–
C5, N1–N5 and J1–J5 based on differential epitope bind-
ing) in the suppressor strain of E. coli XL1-Blue with their
facility of expression as non-fused scFvs in the non-sup-
pressor strain HB2151. We observed a strong level of pos-
itive correlation between relative overall non-fused scFv
expression and relative display level propensity.
Results and discussion
Phage display propensity of scFvs is a variable and clone-
specific characteristic
Phage from E. coli XL1-Blue cultures harbouring 15 differ-
ent anti-Hc scFvs were made, concentrated, purified and
quantified by UV spectroscopy (data not shown). Equal
numbers of phage particles were blotted onto nitrocellu-
lose following electrophoretic separation. All phage-scFv
fusions were probed with either a monoclonal anti-pIII
IgG antibody (Figure 1a) or monoclonal anti-his6 IgG
antibody (Figure 1b). The helper phage only control
showed a dominant band migrating at approximately 70
kDa with a variety of commonly observed smaller MWPage 2 of 10
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15 anti-Hc phage fusions showed a dominant pIII signal
at 70 kDa, that was consistent from clone to clone indicat-
ing uniform loading of phage particles displaying each of
the anti-Hc scFvs and a less dominant higher MW band
migrating at 100 kDa, the density of which varied from
clone to clone. Anti-his6 immuno-detection for the 15
anti-Hc scFvs varied in intensity from clone to clone and
was often observed in two bands at both 70 kDa and 100
kDa. Based on the distribution and signal of pIII and his6
bands it is possible to conclude that the 100 kDa bands in
Figure 1a solely represent full-length scFv fused to full
length pIII. The 70 kDa bands are likely to be due to both
wild-type pIII (major species) and pIII appended to the
his6 tag of the scFv only (minor and indistinguishable).
The remainder of the scFv molecule may have been
cleaved away by proteolytic activity. It may also be possi-
ble that the 70 kDa species represents full length scFv
fused to degraded pIII (also indistinguishable). It is also
worth noting that previous investigations reveal unex-
pected electrophoretic migration of pIII due to its high
glycine content, extended shape and multi-domain struc-
ture leading to differences between calculated and
expected molecular weights and this may have contrib-
uted to the results observed here [33,34].
Quantitative laser scanning densitometry was used to
measure the intensity of the chemiluminescent signal pro-
duced by the western blot analyses (data not shown). The
total signal obtained from both the 100 kDa and 70 kDa
anti-his6 signals was used as a measure of display. Regard-
less of whether the full length scFv is present, detection of
the his6 tag logically dictates display of that scFv protein
on phage. This takes into account degradation (unlike the
pIII blot signal). Data analysis was conducted using the
AIDA Image Analyser Software and the absolute intensi-
ties were corrected for local background signal and nor-
malised for phage loading (using anti-pIII signal) and
Analysis of scFv phage display propensityFigure 1
Analysis of scFv phage display propensity. Each of the 15 scFv-phage clones and helper phage were produced in E. coli 
(XL1-Blue), equalised, electrophoresed by SDS-PAGE, blotted and probed with (a) anti-pIII antibody to demonstrate equalised 
phage titre or (b) anti-his6 antibody to detect varying levels in display of scFv on phage, as described above. The absolute chemi-
luminescent signals were measured by densitometry. (c) Binding to undiluted phage coated onto an immunosorbent plate was 
measured by ELISA to determine levels of pIII and his6 using the same antibodies above. ELISA error bars represent standard 
error from triplicate measurements. Grey bars represent mean anti-pIII signal and white are mean anti-his signal. A represent-
ative data set is shown from one batch of each phage-scFv for both the western blot and ELISA methods. Three independently 
produced batches of phage were analysed.Page 3 of 10
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pensity for three independently produced batches of
phage (See additional file 1). An ELISA platform was used
to support the display level data obtained by western blot
(Figure 1c). Coating of neat, PEG-purified phage (to
remove any contaminating soluble scFv) without prior
OD normalisation was amenable with this assay platform
since variation in titre, as indicated by differences in pIII
signal, could be accounted for by obtaining a ratio of his6
to pIII OD450 values and this was used to produce display
rankings.
Three independently-produced batches of the 15 anti-Hc
phage-scFvs were analysed by both the western blot and
ELISA method described above. Average rankings from 1
(highest displaying scFv) to 15 (lowest displaying scFv)
(Table 1) were used to conduct a Spearmans correlation
analysis comparing rankings obtained between phage-
scFv batches and between the two measurement tech-
niques. Ranks correlated well between batches and tech-
niques (See additional file 1) with clones showing strong
anti-his6 western blot signals also showing high anti-
his6:anti-pIII ELISA ratios (e.g clones C3, C4, C5, N2 &
J2). Thus display level appears to be a non-batch depend-
ent but clone-specific characteristic and varies markedly
between clones in a panel of 15 anti-Hc scFvs.
This variability in display level was not unexpected given
that these clones were derived after only 2 rounds of selec-
tion on the Hc antigen (Scott et al, manuscript in prepara-
tion). Such differences in display level may have
implications in selections such that scFvs exhibiting a
higher display level may be preferentially enriched in the
absence of vastly differing affinities. Given that scFvs have
been shown to be relatively resistant to premature
cytosolic folding/aggregation [31,32], we hypothesised
that the display level variation shown here is due to varia-
tion in the overall expression level of the scFvs with the
reasonable assumption that facility for translocation to
the periplasm is uniform amongst the 15 clones.
Overall scFv expression does not correlate with soluble 
levels in the periplasm and culture supernatant
We found that the overall level of scFv expression defined
as levels measured by western blot in the spheroplast frac-
tion of E. coli HB2151 does not correlate with soluble lev-
els in the periplasmic or culture supernatant fractions after
16 hr culture induction.
Spheroplast, periplasmic and supernatant fractions were
isolated from the cultures at the end of the 16 hr induc-
tion period following normalisation of the culture density
of each clone. Fractionated samples were electrophoresed
and transferred onto nitrocellulose for probing with an
anti-his6 antibody (Figure 2a–c). The supernatant and
periplasmic fractions of each anti-Hc scFv exhibited a sin-
gle band at approximately 30 kDa indicating fully proc-
essed scFv. The spheroplast fractions of most scFvs
Table 1: Average relative rankings of scFv expression levels in various E. coli compartments and levels of display on filamentous 
phage.
Average scFv Rankings Major Germline Families
Clone Supernatant Periplasm Spheroplast Display VH VL
C1 6.0 ± 1 9.8 ± 0.8 7.0 ± 1.2 11.7 ± 1.1 VH4 VL3
C2 6.0 ± 0 14.3 ± 0.7 3.0 ± 0.6 6.2 ± 0.5 VH1 VL3
C3 7.5 ± 0.5 3.5 ± 0.5 8.7 ± 2.9 6.3 ± 1.0 VH4 VK1
C4 14.5 ± 0 11.8 ± 1.2 4.0 ± 1.5 4.2 ± 1.2 VH4 VK1
C5 14.5 ± 0 6.0 ± 1 3.7 ± 1.5 2.7 ± 0.3 VH4 VK1
N1 10.0 ± 2 13.8 ± 3.5 10.0 ± 0.6 7.5 ± 2.2 VH2 VK1
N2 4.0 ± 0 4.5 ± 2.2 3.3 ± 1.9 2.8 ± 1.1 VH1 VK1
N3 13.0 ± 0 10.8 ± 0.5 12.0 ± 0 11.5 ± 0.9 VH3 VK1
N4 9.0 ± 0 3.5 ± 0.5 9.3 ± 2.0 12.2 ± 1.1 VH3 VL2
N5 8.3 ± 3.3 4.3 ± 2.7 11.0 ± 1.0 10.7 ± 1.6 VH3 VL1
J1 10.5 ± 0.5 9.0 ± 3 14.7 ± 0.3 12.2 ± 1.1 VH3 VL2
J2 2.0 ± 0 11.8 ± 1.8 4.0 ± 1.5 3.8 ± 0.5 VH1 VK1
J3 2.0 ± 1 3.8 ± 2.2 5.3 ± 1.3 6.5 ± 1.3 VH3 VL2
J4 2.0 ± 1 3.5 ± 1.5 10.0 ± 1.0 11.3 ± 0.7 VH6 VL2
J5 10.8 ± 0.7 10.0 ± 1 14.0 ± 0.6 11.3 ± 1.5 VH3 VL2
Densitometry data derived from the western blots shown in Figures 1 and 2 were used to rank scFvs from 1 to 15 in order of highest to lowest 
levels of scFv respectively. Rankings from repeat experiments were averaged and are shown here along with standard error for the overall 
expression and display levels. The average relative spheroplast scFv level rankings were used as an indicator of overall expression level and to 
designate the scFvs into three groups of either "high (average ranking ≤ 5; bold numbers)", "medium (average ranking ≥ 5 but ≤ 10; italicised 
numbers) " or "low" (average ranking ≥ 11; No Shading) expression. Rankings for phage display propensity were also used to assign similar 
groupings. The major VH and VL germline designations for each scFv are also shown for each clone.Page 4 of 10
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to represent both N-terminally processed and unproc-
essed scFv in addition to smaller breakdown products.
The absolute signals vary markedly between scFv clones in
each of the three fractions. Quantitative laser scanning
densitometry measurements of western blot chemilumi-
nescence were acquired (data not shown) and used to
rank scFvs from 1 (high) to 15 (low) in order of densitom-
etry signals for levels of scFv present in the E. coli sphero-
plast, periplasmic lysate and culture supernatant. The
overall rankings were reproducible between data sets (See
additional file 1) for the same E. coli compartment indi-
cating that overall scFv expression (spheroplast level) and
localisation to the periplasm and culture supernatant in
soluble form are clone-specific characteristics, that vary
from clone to clone.
Average rankings were produced for each compartment
using independently produced data sets (Table 1) and
these were used to conduct a Spearmans correlation test in
order to determine if relative levels of scFv present within
the three fractions correlate with each other for each
clone. For n = 15, a Rho value greater than 0.441 indicates
positive correlation with a p-value of less than or equal to
0.05. However, comparison of supernatant scFv levels
with periplasmic or spheroplast levels yielded coefficients
of 0.38 and 0.37 respectively. Comparison of periplasmic
and spheroplast levels yielded a coefficient of 0.13. These
data suggest there is no significant correlation (p > 0.05)
between the overall expression level of a scFv molecule as
defined by its spheroplast level, and its relative soluble
levels within the periplasmic space or culture supernatant.
Compartmental analysis of overall relative levels of scFv expression in Escherichia coliFigure 2
Compartmental analysis of overall relative levels of scFv expression in Escherichia coli. Each of the 15 scFv clones 
were produced in E. coli (HB2151). The cultures were equalised for bacterial density and the supernatant, periplasmic and 
spheroplast fractions were electrophoresed by SDS-PAGE and blotted. Anti-his6 antibody was used to probe for the scFvs, 
developed by chemiluminescence. (a) supernatant fraction, (b) periplasmic fraction and (c) spheroplast E. coli pellet. The blot is 
representative of three independent experiments conducted on independently produced samples. (d) Pre-induction (grey bars) 
and final culture densities (white bars) measured by OD600 are also shown and represent mean values from three independent 
experiments.Page 5 of 10
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culture density, as determined by OD600 after a 16 hr
induction, reached a value reproducibly characteristic to
the clone being studied ranging from 0.8 for C2 to 1.7 for
N4 (Figure 2d). Relative increases in culture density fol-
lowing induction were calculated using the mean culture
density data shown in Figure 2d. The relative increases
were used to rank the scFvs from 1 (highest fold increase)
to 15 (lowest fold increase) and used to determine Spear-
mans correlation coefficients in pair-wise comparisons
with spheroplast, periplasmic and culture supernatant
scFv level rankings. Although there was no detectable cor-
relation between relative increase in culture density rank-
ing and spheroplast or periplasmic scFv level rankings,
there was a moderate but statistically significant negative
correlation (Rho = -0.55, p < 0.05) when compared with
culture supernatant scFv levels. Thus scFv clones that
exhibit a low relative level of culture supernatant localisa-
tion allow the bacteria harbouring them to attain a higher
culture density than other scFvs.
Given that scFvs are not prone to cytosolic aggregation,
the lack of correlation between the spheroplast and peri-
plasmic levels of scFv may be explained by differential tox-
icity once in the periplasm. Our culture density data
suggests that some scFvs are more toxic than others and
that clones with a high level of supernatant localisation
hinder bacterial growth following induction, perhaps
through lytic mechanisms or destabilisation of the outer
membrane. This non-uniform differential soluble scFv
localisation therefore directly influences any correlation
between supernatant levels and periplasm, and superna-
tant/periplasm with spheroplast levels. Differing levels of
toxicity may be due to periplasmic aggregation and hence
inclusion body formation, proteolytic breakdown or mis-
folding due to inappropriate disulphide bond formation
which has been observed previously for scFvs [23,35].
Phage display propensity exhibits strong positive 
correlation with overall scFv expression Levels
The average relative scFv rankings for display level pro-
pensity were compared with the expression analysis of
non-fused scFv. We found that display level ranking does
not correlate with soluble scFv level rankings in either the
periplasm (Rho = 0.25; p > 0.05) or supernatant (Rho =
0.20; p > 0.05). However, we found a strong positive cor-
relation (Rho = 0.88; p < 0.005) between display level
ranking and overall scFv expression ranking as defined by
relative spheroplastic levels, illustrated in Figure 3. Based
on the ranking data, scFv clones were grouped into 'high',
'medium' or 'low' for phage display propensity and over-
all expression levels (Table 1). Display ranking was
achieved using two independent methods on three inde-
pendent batches of material and was remarkable consist-
ent (See additional file 1). The average ranking was at
worst, only varied by 2 places (clone N1). Total expression
ranking was also very consistent with clone C3 being the
most variable. Taking all factors into account, we believe
this to be a robust and strong correlation.
This interesting correlation provides insight into the pos-
sible mechanism leading to a lack of correlation between
overall scFv expression and soluble levels in the periplasm
and supernatant. Assembly of pIII-scFv fusion proteins
into phage particles is dependant upon their translocation
to the periplasm [30]. Since overall expression level corre-
lates strongly with display level, it may be concluded that
few of these scFv clones exhibit a marked level of prema-
ture folding or degradation in the bacterial cytosol that
may hinder their translocation to the periplasm. Any
degree of premature folding may be assumed to be uni-
form amongst the 15 clones since the only factor influenc-
Overall levels of scFv expression exhibit strong positive cor-relation with phage display propensityFigure 3
Overall levels of scFv expression exhibit strong posi-
tive correlation with phage display propensity. Aver-
age relative rankings obtained for overall scFv expression in 
the spheroplast fraction of E. coli are displayed on a scatter-
plot in relation to average relative phage display propensity 
rankings for each individual clone. A ranking of 1 represents a 
high relative level of overall expression or phage display pro-
pensity and a ranking of 15 represent a low relative level of 
overall expression or phage display propensity. The plot 
shows a strong positive correlation between expression 
ranking and display level ranking. Each scFv x-axis co-ordi-
nate represents the average ranking from 3 independent 
experimental observations of overall scFv expression (Table 
1). Each scFv y-axis co-ordinate represents the average rank-
ing from 6 independent experimental observations of display 
level (three ELISA and three western blots) carried out on 
three batches of phage-scFv (Table 1). The Spearmans coeffi-
cient of rank correlation Rho coefficient for this association 
is 0.88 representing strong positive correlation with a p-value 
< 0.005. Standard errors are not conventionally used for 
averages of ranks. However they have been calculated (Table 
1) and are not shown graphically for purposes of clarity.Page 6 of 10
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expressed in the bacterial cytosol. Given that scFv expres-
sion in both pIII-fused and non-fused forms share the
same secretary signal sequence it can be assumed that
both are trafficked to the periplasm in an identical man-
ner. We would therefore expect levels of soluble scFv in
the periplasm to correlate with overall expression level
and display level. This was not the case.
A hypothetical explanation for the observed disparity
therefore potentially lies in the fact that the fates of pIII
fused and non-fused scFvs diverge once the proteins are
translocated across the inner membrane of E. coli. The
pIII-scFv fusion remains anchored in the inner membrane
via the C-terminal domain of pIII [13] whereas free scFv
remains in the periplasmic space where it is subject to
potential mis-folding or aggregation. We propose that dif-
ferential levels of aggregation between clones at this stage
leads to varying degrees of membrane destabilisation and
therefore leaking of scFv into the supernatant.
Codon usage indirectly influences scFv phage display 
propensity
Figure 4 shows the amino acid sequences of the 15 anti-
tetanus toxin Hc scFvs aligned by homology. The major
germline constituents of the scFv VH and VL domains were
determined (Table 1) in order to evaluate whether partic-
ular germline sequences are more amenable to expression
in E. coli and hence display on phage. It seems that scFvs
exhibiting a high level of display and expression often har-
bour a VK1 derived VL domain and those exhibiting low
expression and display tend to harbour a VH3 derived VH
domain. These observations support earlier work where
Ewert et al [31] analysed total soluble expression of indi-
vidual and paired V-domains. Here also, VH3 subtype was
best and most soluble VH domain and VK1 was also
ranked highly. It was not possible to elucidate definite D
and J segment germline designations for the scFv VH and
VL domains since they appear to have undergone signifi-
cant affinity maturation. This is not unexpected as the
library used was derived from a pool of individuals many
of whom were likely to have been immunised against tet-
anus, leading to antibody affinity maturation.
The link between total protein expression and phage dis-
play is supported by bioinformatics analyses. A number of
factors influence translation efficiency, codon usage being
an important parameter [14,15]. One codon usage index
is the codon adaptation index (CAI) [36] which was deter-
mined using the codonW programme [37]. Ranking of the
CAI correlates with overall expression and hence phage
display (Rho = 0.68 p < 0.01). At the nucleotide level, the
scFv sequences are similar (See additional file 2) and the
CAI covers a small range, suggesting that minor differ-
ences in codons could account for large differences in dis-
Annotated amino acid sequence alignment of the 15 anti-Hc scFvsFigure 4
Annotated amino acid sequence alignment of the 15 
anti-Hc scFvs. The amino acid sequences of 15 anti-Hc 
scFvs C1–C5, J1–J5 and N1–N5 were aligned using ClustalW 
[45]. The inter-domain linker (G4S)3 joins the N-terminal VH 
domain to the C-terminal VL domain of the scFv. Within each 
of the VH and VL domains, there are three areas of increased 
diversity indicating the hypervariable complimentarity deter-
mining regions (labelled). Identically-conserved residues are 
labelled (*), conserved residues are labelled (:) and similar 
residues are labelled (.) The protein and corresponding DNA 
sequences (See additional file 2) have been deposited in the 
EMBL database.Page 7 of 10
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used to search for DNA motifs which could be linked to
high expression. However, many motifs were identified
and given the similar nucleotide backgrounds, it was
impossible to deduce which ones could be of significance
and which ones were signatures of the V-gene sequences.
A similar protein sequence analysis failed to identify any
protein motifs which correlate with phage display propen-
sity. This confirms that phage display of scFvs is closely
and significantly linked to overall protein expression and
not post-translational protein-orientated events such as
folding. There is a great deal of research detailing protein
sequence motifs which affect functional protein expres-
sion, particularly recombinant antibodies [23,39]. This is
likely to affect the levels of scFv found in the supernatant.
Antibody V-domains are generally homologous with a
consensus homology of approximately 50% [40]. The
data in this study comprises V-domains ranging from
highly similar sequences to around 60% homology (Fig.
4). Given that even a single residue change can influence
major biophysical properties [23], making observations
with highly similar sequences is still valid for this compar-
ative analysis.
Conclusion
In conclusion, when premature protein folding in the bac-
terial cytosol is not a factor, phage display levels correlate
with overall expression level. Higher levels of synthesised
protein result in greater levels of inner membrane translo-
cation and incorporation into phage particles. Therefore,
factors influencing overall expression indirectly influence
phage display propensity. This suggests that better scFv
display could be achieved in codon-optimised strains of
E. coli such as those commercially available or in vectors
with very strong promoters such as the T7-promoter sys-
tem. However, high levels of overall expression may not
necessarily imply high levels of soluble localisation to the
periplasm or supernatant. This may influence selection of
clones for further study after phage display suggesting that
a parallel screen of periplasmic or supernatant levels
should be conducted in order to select clones that exhibit
a desirable high soluble yield in addition to phage ELISAs.
The work also shows how scFv display level and expres-
sion can vary considerably amongst clones despite an
overall high level of sequence homology.
Materials and methods
Production and isolation of phage-scFv fusions
A description of the selection and full characterisation of
these 15 anti-tetanus toxin scFvs is in preparation (Scott,
N et al, manuscript in preparation). All scFvs were selected
on plastic immobilised recombinant tetanus toxin Hc-
domain using Nunc immunotubes at high antigen con-
centrations. This allowed selection of a diverse array of
binders with no selection pressure on affinity, display or
expression.
The amber suppressor XL1-Blue strain of Escherichia coli
(Stratagene) was transformed [41] with the phagemid vec-
tor pCANTAB6 [29] encoding each of the fifteen anti-Hc
scFvs C1–C5, N1–N5 and J1–J5 under the control of the lac
promoter. Individual transformant colonies of each scFv
clone were selected and grown for 16 hours in a 5 ml cul-
ture of 2TY [41] containing 100 μg/ml carbenicillin, 15 μg/
ml tetracycline and 1% glucose, with shaking at 250 rpm.
The cultures were sub-cultured, after removal of old
medium, at a 1:100 ratio into 50 ml of fresh medium and
grown at 37°C with shaking at 250 rpm. At an OD600 of
0.4–0.5, the phagemid containing bacteria were infected
with VCSM13 helper phage (Stratagene) at a multiplicity of
infection of 20:1 [42]. Infection was allowed to take place
for 30 minutes at 37°C without shaking followed by a fur-
ther 30 minutes at 37°C with shaking at 200 rpm. The bac-
teria were isolated by centrifugation and resuspended in 50
ml of 2TY containing 100 μg/ml carbenicillin and 50 μg/ml
kanamycin. The cultures were incubated overnight at 30°C
with shaking at 300 rpm. The culture supernatants were
clarified by centrifugation and filtered through a 0.44 μm
membrane. A third volume of ice-cold 20% polyethylene
glycol 8000 containing 2.5 M NaCl was mixed with the
phage containing supernatant and the solution incubated
for 2 hours at 4°C. Precipitated phage were isolated by cen-
trifugation at 4000 rpm for 1 hour at 4°C and resuspended
in commercial phosphate buffered saline (PBS) (pH 7.4) to
a volume one tenth the original culture volume. A final cen-
trifuge step at 13,000 rpm was used to remove any debris.
Phage titre was estimated for each phage-scFv clone using
UV spectroscopy (OD270 = 1 is equivalent to 1.1 × 1013
phage particles per millilitre) [43].
Expression of non-fused scFv and isolation of spheroplast, 
periplasmic and supernatant fractions
The DNA encoding the fifteen anti-Hc scFvs in phagemid
pCANTAB6 were transformed into the HB2151 (GE
Healthcare, UK) strain of E. coli which produces only scFv
rather than a mixture of non-fused scFv and scFv-pIII
fusion since translation terminates at the amber TAG
codon separating the two genes. The clones were grown
for 16 hours at 37°C in 2TY broth containing 1% glucose
and 100 μg/ml carbenicillin with shaking at 250 rpm.
After removal of old medium the cells were sub-cultured
at a 1:100 ratio into 10 ml of fresh medium and grown to
an OD600 of between 0.6 and 0.8 at 37°C with shaking at
250 rpm [42]. At this point the bacteria were isolated by
centrifugation and resuspended in 10 ml of 2TY medium
containing 100 μg/ml carbenicillin and 1 mM IPTG to
induce expression of the non-fused scFv genes. The cul-
tures were incubated overnight at 30°C with shaking at
300 rpm. The OD600 was measured at the end of this
period and the culture volumes adjusted with 2TY broth
in order to normalise the bacterial density to that of the
lowest clone. The cultures were centrifuged at 4000 rpm
for 1 hour at 4°C and the supernatant retained. The bac-Page 8 of 10
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extraction buffer containing 500 mM sucrose 100 mM
Tris-HCl, 1 mM EDTA pH 8.0 [44]. The volume of buffer
used was one-tenth the final OD normalised volume. The
resuspended bacteria were mixed by vortexing for 10 sec-
onds every 5 minutes for 20 minutes in order to break
open the outer membrane of the bacteria. Spheroplasts
were then isolated by centrifugation at 13,000 rpm for 30
minutes at 4°C and the supernatant (periplasmic frac-
tion) retained. The spheroplast containing pellet was re-
suspended in distilled H20 at one-tenth the volume of OD
normalised culture volume.
Measurement of phage display levels and non-fused scFv 
expression using western blot with quantitative laser 
scanning densitometry analysis
For measurement of phage display propensity, equal num-
bers of phage displaying each of the 15 scFv clones and a
helper phage control were subject to reducing SDS-PAGE
and subsequently electroblotted onto nitrocellulose. Each
clone and the helper phage were probed with a murine
anti-pIII antibody (Clone 10C3, MoBiTec, Germany-which
recognises a 10 residue C-terminal epitope, thus suitable
for investigating degraded scFv-pIII fusion proteins) fol-
lowed by a goat anti-mouse HRPO secondary. Simultane-
ously the samples were probed with HRPO conjugated
murine anti-his6 antibody (Sigma). The detection of pIII is
a measure of total phage present and the measurement of
the his6 tag indicates levels of scFv displayed. In the case of
non-fused scFv, the supernatant (5 μl), periplasmic (0.5 μl)
and supernatant (0.5 μl) fractions were subjected to reduc-
ing SDS-PAGE and electroblotted onto nitrocellulose.
Probing with anti-his6 HRPO was used to measure the scFv
levels. In both the case of measuring levels of scFv fused to
phage and of non-fused scFv, western blots were developed
using the ECL plus western blotting detection system.
Chemiluminescent signals were detected and measured
using quantitative laser scanning densitometry [LAS3000
CCD Imaging System] (Fujifilm, Japan) facilitated with the
AIDA Biopackage image analyser software (Raytest, Ger-
many). Absolute signal intensities derived from the chemi-
luminescent signal were corrected for local background
signal and used to produce a relative ranking of scFv display
level and levels of non-fused scFv in spheroplast, periplasm
and supernatant.
Measurement of scFv display level by ELISA
As an additional measurement of scFv levels on phage, an
ELISA methodology was used. Undiluted phage (100 μl)
were coated onto 96-well Maxisorp Nunc-Immunoplates.
Following a blocking step with Marvel™ dried milk pow-
der pIII and his6 immunodetection were facilitated with
the antibodies used during the western blot procedure.
The assay was developed using BM-Blue POD substrate
and stopped with 1 M HCL. Binding signal (OD450) was
measured using a SpectraMax 340PC plate reader. A ratio
of pIII to his6 OD450 values was used as an indication of
relative display level to account for variation in phage titre
and rankings were produced accordingly.
Statistical analyses
Statistical assessment including derivation of means and
standard errors was carried out using the Sigma Plot Soft-
ware Version 8.0 (Systat Software Inc., London). Compar-
ison of scFv rankings between different sample sets was
facilitated through calculation of the Spearmans Coeffi-
cient of Rank Correlation parameter (Rho) which shows
the degree of correlation and its statistical significance.
Abbreviations
OD600: Optical density at 600 nm; HRPO: Horse-radish-
peroxidise; ELISA: Enzyme linked immuno-sorbant assay;
scFv: Single chain Fv; E. coli: Escherichia coli; Hc: Tetanus
toxin heavy chain C-terminal domain; his6: Hexahistidine
epitope tag; pIII: Minor protein 3 of phage.
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